Takeda Pharmaceutical Company Limited
Heterocyclic amide compound
Last updated:
Abstract:
Provided is a heterocyclic amide compound that may have a PRS inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for PRS associated diseases and the like including cancer. A compound represented by the following formula (I): ##STR00001## wherein a group represented by ##STR00002## is a group represented by the following formula (II) or the following formula (III): ##STR00003## and other symbols are as described in the DESCRIPTION, or a salt thereof.
Status:
Grant
Type:
Utility
Filling date:
14 Sep 2017
Issue date:
15 Sep 2020